Blog

Emerging Immunotherapy in Advanced Renal Cell Carcinoma. – UroToday

Emerging Immunotherapy in Advanced Renal Cell Carcinoma.
UroToday
Immunotherapy has recently catapulted to the forefront of treatments for patients with solid tumors. Given its inherent immunogenic properties, renal cell carcinoma (RCC) has historically responded to immunotherapy and remains primed for further …

2017-09-22 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.